▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information.

Spikevax JN.1 is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older. The use of this vaccine should be in accordance with official recommendations.

If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in the package leaflet. You can also report a side effect at any time by visiting by visiting the UK's MHRA Yellow Card Reporting Site or by visiting Moderna's Adverse Event Intake Portal.

By reporting side effects you can help provide more information on the safety of this medicine.